A systematic review of cellular transplantation therapies for spinal cord injury
- PMID: 20146557
- PMCID: PMC3143488
- DOI: 10.1089/neu.2009.1177
A systematic review of cellular transplantation therapies for spinal cord injury
Abstract
Cell transplantation therapies have become a major focus in pre-clinical research as a promising strategy for the treatment of spinal cord injury (SCI). In this article, we systematically review the available pre-clinical literature on the most commonly used cell types in order to assess the body of evidence that may support their translation to human SCI patients. These cell types include Schwann cells, olfactory ensheathing glial cells, embryonic and adult neural stem/progenitor cells, fate-restricted neural/glial precursor cells, and bone-marrow stromal cells. Studies were included for review only if they described the transplantation of the cell substrate into an in-vivo model of traumatic SCI, induced either bluntly or sharply. Using these inclusion criteria, 162 studies were identified and reviewed in detail, emphasizing their behavioral effects (although not limiting the scope of the discussion to behavioral effects alone). Significant differences between cells of the same "type" exist based on the species and age of donor, as well as culture conditions and mode of delivery. Many of these studies used cell transplantations in combination with other strategies. The systematic review makes it very apparent that cells derived from rodent sources have been the most extensively studied, while only 19 studies reported the transplantation of human cells, nine of which utilized bone-marrow stromal cells. Similarly, the vast majority of studies have been conducted in rodent models of injury, and few studies have investigated cell transplantation in larger mammals or primates. With respect to the timing of intervention, nearly all of the studies reviewed were conducted with transplantations occurring subacutely and acutely, while chronic treatments were rare and often failed to yield functional benefits.
Similar articles
-
Transplantation of bone marrow stromal cell-derived neural precursor cells ameliorates deficits in a rat model of complete spinal cord transection.Cell Transplant. 2013;22(9):1613-25. doi: 10.3727/096368912X658791. Epub 2012 Oct 31. Cell Transplant. 2013. PMID: 23127893
-
Cell-based transplantation strategies to promote plasticity following spinal cord injury.Exp Neurol. 2012 May;235(1):78-90. doi: 10.1016/j.expneurol.2011.02.010. Epub 2011 Feb 17. Exp Neurol. 2012. PMID: 21333647 Review.
-
Transplantation of human marrow stromal cells and mono-nuclear bone marrow cells into the injured spinal cord: a comparative study.Spine (Phila Pa 1976). 2009 Nov 15;34(24):2605-12. doi: 10.1097/BRS.0b013e3181bdca87. Spine (Phila Pa 1976). 2009. PMID: 19881401
-
Bladder function recovery in rats with traumatic spinal cord injury after transplantation of neuronal-glial restricted precursors or bone marrow stromal cells.J Urol. 2009 Jun;181(6):2774-9. doi: 10.1016/j.juro.2009.01.093. Epub 2009 Apr 17. J Urol. 2009. PMID: 19375728
-
Stem cell-based cell therapy for spinal cord injury.Cell Transplant. 2007;16(4):355-64. doi: 10.3727/000000007783464885. Cell Transplant. 2007. PMID: 17658126 Review.
Cited by
-
The Efficacy of Different Material Scaffold-Guided Cell Transplantation in the Treatment of Spinal Cord Injury in Rats: A Systematic Review and Network Meta-analysis.Cell Mol Neurobiol. 2024 May 4;44(1):43. doi: 10.1007/s10571-024-01465-6. Cell Mol Neurobiol. 2024. PMID: 38703332 Free PMC article. Review.
-
Stepwise combined cell transplantation using mesenchymal stem cells and induced pluripotent stem cell-derived motor neuron progenitor cells in spinal cord injury.Stem Cell Res Ther. 2024 Apr 23;15(1):114. doi: 10.1186/s13287-024-03714-3. Stem Cell Res Ther. 2024. PMID: 38650015 Free PMC article.
-
Cell Transplantation for Repair of the Spinal Cord and Prospects for Generating Region-Specific Exogenic Neuronal Cells.Cell Transplant. 2024 Jan-Dec;33:9636897241241998. doi: 10.1177/09636897241241998. Cell Transplant. 2024. PMID: 38590295 Free PMC article. Review.
-
Improved Efficacy of Delayed Treatment with Human Bone Marrow-Derived Stromal Cells Evaluated in Rats with Spinal Cord Injury.Int J Mol Sci. 2024 Jan 26;25(3):1548. doi: 10.3390/ijms25031548. Int J Mol Sci. 2024. PMID: 38338827 Free PMC article.
-
Advancing Spinal Cord Injury Treatment through Stem Cell Therapy: A Comprehensive Review of Cell Types, Challenges, and Emerging Technologies in Regenerative Medicine.Int J Mol Sci. 2023 Sep 20;24(18):14349. doi: 10.3390/ijms241814349. Int J Mol Sci. 2023. PMID: 37762654 Free PMC article. Review.
References
-
-
Schwann cells
- Agudo M. Woodhoo A. Webber D. Mirsky R. Jessen K.R. McMahon S.B. Schwann cell precursors transplanted into the injured spinal cord multiply, integrate and are permissive for axon growth. Glia. 2008;56:1263–1270. - PubMed
-
-
- Azanchi R. Bernal G. Gupta R. Keirstead H.S. Combined demyelination plus Schwann cell transplantation therapy increases spread of cells and axonal regeneration following contusion injury. J. Neurotrauma. 2004;21:775–788. - PubMed
-
- Bamber N.I. Li H.Y. Lu X.B. Oudega M. Aebischer P. Xu X.M. Neurotrophins BDNF and NT-3 promote axonal re-entry into the distal host spinal cord through Schwann cell-seeded mini-channels. Eur. J. Neurosci. 2001;13:257–268. - PubMed
-
- Barakat D.J. Gaglani S.M. Neravetla S.R. Sanchez A.R. Andrade C.M. Pressman Y. Puzis R. Garg M.S. Bunge M.B. Pearse D.D. Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord. Cell Transplant. 2005;14:225–240. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical